721 related articles for article (PubMed ID: 31782760)
1. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
[TBL] [Abstract][Full Text] [Related]
2. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer's disease.
Morrone CD; Lai AY; Bishay J; Hill ME; McLaurin J
Transl Neurodegener; 2022 May; 11(1):26. PubMed ID: 35501886
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
4. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
5. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
[TBL] [Abstract][Full Text] [Related]
6. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
[TBL] [Abstract][Full Text] [Related]
7. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
[TBL] [Abstract][Full Text] [Related]
8. Heightened Hippocampal β-Adrenergic Receptor Function Drives Synaptic Potentiation and Supports Learning and Memory in the TgF344-AD Rat Model during Prodromal Alzheimer's Disease.
Goodman AM; Langner BM; Jackson N; Alex C; McMahon LL
J Neurosci; 2021 Jun; 41(26):5747-5761. PubMed ID: 33952633
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatments with a 5-HT
Baranger K; Giannoni P; Girard SD; Girot S; Gaven F; Stephan D; Migliorati M; Khrestchatisky M; Bockaert J; Marchetti-Gauthier E; Rivera S; Claeysen S; Roman FS
Neuropharmacology; 2017 Nov; 126():128-141. PubMed ID: 28844596
[TBL] [Abstract][Full Text] [Related]
10. Memory performance is related to amyloid and tau pathology in the hippocampus.
Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.
Lace G; Savva GM; Forster G; de Silva R; Brayne C; Matthews FE; Barclay JJ; Dakin L; Ince PG; Wharton SB;
Brain; 2009 May; 132(Pt 5):1324-34. PubMed ID: 19321462
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
14. Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
Bazzigaluppi P; Beckett TL; Koletar MM; Lai AY; Joo IL; Brown ME; Carlen PL; McLaurin J; Stefanovic B
J Neurochem; 2018 Mar; 144(5):669-679. PubMed ID: 28777881
[TBL] [Abstract][Full Text] [Related]
15. Entorhinal-Hippocampal Circuit Integrity Is Related to Mnemonic Discrimination and Amyloid-β Pathology in Older Adults.
Adams JN; Kim S; Rizvi B; Sathishkumar M; Taylor L; Harris AL; Mikhail A; Keator DB; McMillan L; Yassa MA
J Neurosci; 2022 Nov; 42(46):8742-8753. PubMed ID: 36302636
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
[TBL] [Abstract][Full Text] [Related]
17. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.
Giannakopoulos P; Herrmann FR; Bussière T; Bouras C; Kövari E; Perl DP; Morrison JH; Gold G; Hof PR
Neurology; 2003 May; 60(9):1495-500. PubMed ID: 12743238
[TBL] [Abstract][Full Text] [Related]
18. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
